Mdoloris Medical Systems – also known as MDMS – have developed the first pain and comfort assessment monitoring system for neonates to assist medical professionals in their practice. The NIPE Monitor allows medical staff to evaluate the parasympathetic tone of newborns, from premature up to the age of two, by means of an electrocardiogram. Without invasive means, this device helps medical staff to reduce infant stress and thus mitigate many risk factors associated with a stressful perinatal environment.

The First Pain and Comfort Assessment Monitoring System for Neonates

A study conducted by Ricardo Carbajal and colleagues in 2008 showed that painful procedures are very common in neonates and young hospitalised children. The authors found that from a sample group of 430 infants, an average of sixteen invasive procedures were performed daily, of which more than 60% were considered painful, and 30% stressful. Further, a vast majority of these procedures were performed without any analgesia.

It is well established that pain and stress experienced by neonates can have a serious impact on neuro development resulting in long-term health consequences and increased risk of cardiovascular and metabolic diseases. Thus, the NIPE Monitor is needed to detect and reduce pain and stress in neonates.

The NIPE Monitor V1 provides a parasympathetic index based on an electrophysiological signal and evaluates it continuously to provide a consistent and objective rating of pain or comfort at all times. Nursing time is reduced thusly, meaning time and financial resources are conserved.

Why It Is Important to Assess Parasympathetic Tone in Newborns

The NIPE Monitor enables medical staff to take objective and constant readings of an infants parasympathetic tone, which correlates directly with the child’s level of discomfort. This technology is suitable to be used with extremely premature babies, from approximately 26 weeks of gestation, right up to the age of two years.

It is particularly important to monitor the levels of pain and stress young infants experience as it is well documented that neonates – particularly premature infants – are severely negatively impacted by painful stimulus.
The NIPE Monitor is non-invasive, and is based on the electrocardiogram taken from the patient monitor in use.

Thus, to reduce the risk of long-term health consequences and neuro developmental issues, the NIPE Monitor can be used in all manner of medical institutions.

Why the NIPE Index from MDMS is Superior

The NIPE Monitor is extremely beneficial to medical institutions in its invaluable parasympathetic assessment. Over and above reducing the risk of pain, stress, and the long-term health consequences thereof in infants, the NIPE Monitor:

  • Can continuously and non-invasively measure pain and stress
  • Provides easy-to-interpret data, either averaged (NIPEm) or instantaneous (NIPEi)
  • Aids nurses in evaluating the impact of environmental conditions on the infant
  • Aids nurses in assessing the positive influences of developmental care activities
  • Evaluates prolonged pain before and during a procedure
  • Assists in adapting analgesia protocols to individual needs
  • Reduces risk of over- and underdosage and associated side effects

NIPE Monitor from GLENMED

You can enquire about the NIPE Monitor from MDMS by contacting us today and we will be sure to get back to you promptly. Our website is home to a multitude of innovative medical equipment and healthcare solutions for your organisation. More in-depth information on the NIPE Monitor can be found here, where a downloadable pdf can be found at the bottom of the page.